Publication Date:
1981-12-11
Description:
Subjects with type III hyperlipoproteinemia develop premature atherosclerosis and have hyperlipidemia due to an increase in cholesterol-rich very low density lipoproteins (VLDL) of abnormal electrophoretic mobility. Apolipoprotein E is a major protein constituent of VLDL and appears to be important for the hepatic uptake of triglyceride-rich lipoproteins. A new kindred of patients with type III hyperlipoproteinemia is described in which no plasma apolipoprotein E could be detected, consistent with the concept that type III hyperlipoproteinemia may be due to an absence or striking deficiency of apolipoprotein E.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Ghiselli, G -- Schaefer, E J -- Gascon, P -- Breser, H B Jr -- New York, N.Y. -- Science. 1981 Dec 11;214(4526):1239-41.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6795720" target="_blank"〉PubMed〈/a〉
Keywords:
Apolipoproteins/blood/*deficiency
;
Apolipoproteins E
;
Humans
;
Hyperlipoproteinemia Type III/*blood/genetics
;
Immunodiffusion
;
Lipoproteins, HDL/blood/*deficiency
;
Lipoproteins, VLDL/blood/*deficiency
;
Pedigree
;
Reference Values
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
